e-Drug3D 403 |
cas 2022-85-7 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
PK parameters F 83 PERCENT |
Target TARGET CYTOSINE DEAMINASE |
DrugCentral Thymidylate synthase UNIPROT P0CS13 TMP1 Thymidylate synthase UNIPROT P12461 TMP1 |
Download SDF file | 4-amino-5-fluoro-3H-pyrimidin-2-one Formula: Calculated chemical properties: MW 129.10 NB_atoms 9 XLogP -0.51 PSA 65.639 NB_HD 3 NB_HA 4 fsp3 0.00 Lipinski(0=no;1=yes) 1 |
FDA NDA 017001 (pdf not found) INN (FLUCYTOSINE) ANCOBON (BAUSCH) APPROVAL= AP YEAR= 1971 NDA 201566 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (SIGMAPHARM LABS LLC) APPROVAL= AP YEAR= 2011 NDA 204652 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (NOVEL LABS INC) APPROVAL= AP YEAR= 2017 NDA 206550 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (HIKMA) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 207536 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (STRIDES PHARMA) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 212632 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (STRIDES PHARMA) APPROVAL= AP YEAR= 2020 NDA 213665 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2020 NDA 218005 (pdf not found) INN (FLUCYTOSINE) FLUCYTOSINE (LAURUS) APPROVAL= AP YEAR= 2025 |
Other links: |